ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013
Delivering high-quality and affordable care throughout the cancer care continuum.
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Global patterns of opioid use and dependence: harms to populations, interventions, and future action.Lancet (London, England) · 2019Pooled it
- Cost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic review.PharmacoEconomics · 2014Pooled it
- Economic evaluation of therapeutic cancer vaccines and immunotherapy: a systematic review.Human vaccines & immunotherapeutics · 2014Pooled it
- Exploring the drivers of price variation in orthopaedic radical bone tumor resection: A nationwide database study.PloS one · 2026Article
- The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system.Breast cancer research and treatment · 2024Article
- Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma: a systematic review and meta-analysis.Cost effectiveness and resource allocation : C/E · 2023Review
- Value-Based Quality Care for Breast Cancer: More Than Guidelines.European journal of breast health · 2021Review
- Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment.PLoS medicine · 2019Article
- Innovating Cancer Care Delivery: the Example of the 4R Oncology Model for Colorectal Cancer Patients.Current treatment options in oncology · 2019Article
- Impact of Appointment Waiting Time on Attendance Rates at a Clinical Cancer Genetics Service.Journal of genetic counseling · 2018Article
- Shining light on advanced NSCLC in 2017: combining immune checkpoint inhibitors.Journal of thoracic disease · 2018Review
- Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care.PharmacoEconomics · 2018Article
- A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment.Cancer · 2017Review
- Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.International journal of radiation oncology, biology, physics · 2017Article
- Predictors of financial difficulties and work modifications among cancer survivors in the United States.Journal of cancer survivorship : research and practice · 2016Article
- The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms.Neuro-oncology · 2016Article
- Article
- American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2015Article
- Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2015Article
- Patients and Physicians Can Discuss Costs of Cancer Treatment in the Clinic.Journal of oncology practice · 2015Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
11 authors.
Funding
Abstract
The national cost of cancer care is projected to reach $173 billion by 2020, increasing from $125 billion in 2010. This steep upward cost trajectory has placed enormous an financial burden on patients, their families, and society as a whole and raised major concern about the ability of the health care system to provide and sustain high-quality cancer care. To better understand the cost drivers of cancer care and explore approaches that will mitigate the problem, the National Cancer Policy Forum of the Institute of Medicine held a workshop entitled "Delivering Affordable Cancer Care in the 21st Century" in October 2012. Workshop participants included bioethicists, health economists, primary care physicians, and medical, surgical, and radiation oncologists, from both academic and community settings. All speakers expressed a sense of urgency about the affordability of cancer care resulting from the future demographic trend as well as the high cost of emerging cancer therapies and rapid diffusion of new technologies in the absence to evidence indicating improved outcomes for patients. This article is our summary of presentations at the workshop that highlighted the overuse and underuse of screening, treatments, and technologies throughout the cancer care continuum in oncology practice in the United States.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.